PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9558037-4	1998	GLP-1 infused intravenously in amounts corresponding to the postprandial release significantly inhibited pentagastrin-stimulated gastric lipase secretion and lipolytic activity.	Pentagastrin	105-117	glucagon	Homo sapiens	0-5	
16401467-9	2006	GLP-2 administration caused an approximately 15% reduction in pentagastrin-stimulated gastric acid and chloride secretion (P < .01), whereas gastric emptying was not affected (P = .99).	Pentagastrin	62-74	glucagon	Homo sapiens	0-5	
9203936-3	1997	AIM/METHODS: The effect of intravenous GLP-1 (7-36 amide) (1 pmol/kg/min) was studied on pentagastrin induced acid secretion in otherwise healthy subjects, previously vagotomised for duodenal ulcer (n = 8) and in a group of young (n = 8) and old (n = 6) healthy volunteers.	Pentagastrin	89-101	glucagon	Homo sapiens	39-44	
2714145-7	1989	GLP-1 reduced the pentagastrin-stimulated acid secretion 16 +/- 9% during the low-rate infusion and 23 +/- 12% during the high rate (P less than 0.05).	Pentagastrin	18-30	glucagon	Homo sapiens	0-5	
15616656-5	1998	At physiological plasma levels GLP-1 inhibits meal- and pentagastrin-induced gastric acid secretion.	Pentagastrin	56-68	glucagon	Homo sapiens	31-36